VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $21,536,000 | +2.6% | 1,502,850 | +23.9% | 0.75% | +3.3% |
| Q2 2017 | $20,981,000 | +1658.7% | 1,212,800 | +18028.6% | 0.72% | +1753.8% |
| Q3 2015 | $1,193,000 | -19.7% | 6,690 | 0.0% | 0.04% | -7.1% |
| Q2 2015 | $1,486,000 | +9.9% | 6,690 | -1.7% | 0.04% | +7.7% |
| Q1 2015 | $1,352,000 | +28.6% | 6,805 | -7.4% | 0.04% | +25.8% |
| Q4 2014 | $1,051,000 | -14.8% | 7,345 | -21.9% | 0.03% | -20.5% |
| Q3 2014 | $1,233,000 | +4.0% | 9,400 | 0.0% | 0.04% | +8.3% |
| Q2 2014 | $1,186,000 | -28.3% | 9,400 | -25.1% | 0.04% | -33.3% |
| Q1 2014 | $1,654,000 | +1.6% | 12,550 | -9.5% | 0.05% | -29.9% |
| Q4 2013 | $1,628,000 | +23.1% | 13,870 | +9.5% | 0.08% | +6.9% |
| Q3 2013 | $1,322,000 | +21.2% | 12,670 | 0.0% | 0.07% | +12.5% |
| Q2 2013 | $1,091,000 | – | 12,670 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |